Apex Healthcare

Equities

AHEALTH

MYL7090OO003

Pharmaceuticals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
3 MYR +0.67% Intraday chart for Apex Healthcare 0.00% +20.48%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023 CI
Apex Healthcare Boosts Dividend Despite Profit Decline in Q4 MT
Apex Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apex Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Apex Healthcare Berhad Announces the Final Single-Tier Dividend for the Financial Year Ended December 31, 2023, Payment Date 29 May 2024 CI
Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023 CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024 CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024 CI
Apex Healthcare Profit Declines in Q3 MT
Apex Healthcare Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Apex Healthcare's Profit Shoots Up in Q2 MT
Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023 CI
Apex Healthcare Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2023, Payable on 19 September 2023 CI
Apex Healthcare's Profit Climbs in Q1 MT
Apex Healthcare Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023 CI
Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non Executive Member of Risk Committee, Effective Form May 18, 2023 CI
Apex Healthcare Berhad Appoints Datuk Noharuddin Bin Nordin @ Harun as Independent and Non Executive Member of Remuneration Committee, Date of Change May 18, 2023 CI
Apex Healthcare Berhad Appoints Leong Khai Cheong as Independent and Non Executive Member of Nomination Committee, Effective Form May 18, 2023 CI
Apex Healthcare Berhad Approves the Special Dividend for the Financial Year Ended 31 December 2022 CI
Apex Healthcare Berhad Approves the Final Single-Tier Dividend for the Financial Year Ended December 31, 2022 CI
Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Director, Effective from May 18, 2023 CI
Apex Healthcare Berhad Announces the Cessation of Datuk Noharuddin Bin Nordin @ Harun as Independent and Non Executive Member of Risk Committee CI
Apex Healthcare Berhad Announces the Retirement of Jackson Chevalier Yap-Kit-Siong, as Member of Remuneration Committee CI
Chart Apex Healthcare
More charts
Apex Healthcare Berhad is a Malaysia-based healthcare company. The Company is focused on the development, manufacturing, wholesaling, marketing and distribution of pharmaceuticals, consumer healthcare products, and medical devices. It operates through three segments: Manufacturing, Distribution and Corporate. It is engaged in the manufacturing of pharmaceutical products. It is involved in the distribution of pharmaceutical and healthcare products. The Corporate segment comprises investments, properties and others. It is also engaged in the contract manufacturing of orthopedic devices. Its brands include XEPATM, AVO, AGNESIA, AEVA and HENNSON, and products bearing these brands are sold in approximately 16 territories worldwide. The Company's distribution channels reach hospitals, clinics, independent and chain pharmacies, supermarkets and health stores, enabling products to reach customers, namely doctors, pharmacists, nutritionists, retailers, and ultimately the patients or consumers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
3 MYR
Average target price
2.644 MYR
Spread / Average Target
-11.87%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AHEALTH Stock
  4. News Apex Healthcare
  5. Apex Healthcare Berhad : Unit to Distribute Sinopharm COVID-19 Vaccine in Singapore